Ignite Creation Date:
2024-05-05 @ 11:31 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00066352
Status:
COMPLETED
Last Update Posted:
2015-07-23
First Post:
2003-08-06
Brief Title:
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder Renal Pelvis or Ureter
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Transitional Cell Cancer of the Renal Pelvis and Ureter |
| Bladder Cancer |
Keywords:
| Name | View |
|---|---|
| transitional cell carcinoma of the bladder | View |
| recurrent bladder cancer | View |
| stage IV bladder cancer | View |
| metastatic transitional cell cancer of the renal pelvis and ureter | View |
| recurrent transitional cell cancer of the renal pelvis and ureter | View |
| regional transitional cell cancer of the renal pelvis and ureter | View |